Dr Mark Iles (Cancer Studies & Pathology) shows that a gene previously shown to be linked to obesity may also increase the risk of a deadly form of skin cancer. For further information click here (March 2013)
Professor Mark Wilcox (Clinical Sciences) comments on article in the British Medical Journal regarding 'faulty' antibiotic test kits putting patients at risk. For further information click here (February 2013)
Professor Alan Melcher (Cancer Studies & Pathology) comments on a genetically engineered virus which can treble the average survival time of people with a severe form of liver cancer. For further information click here (February 2013)
Professor Mark Wilcox (Clinical Sciences) presents his preliminary findings on a new biosensor which can identify all bacteria, viruses and fungi known to cause infectious disease in humans. For further information click here (February 2013)
Professor Philip Conaghan (Rheumatic & Musculoskeletal Diseases) explains how cartilage has faults that lead to disease and injury. For further information click here (February 2013)
Professor Simon Kay (Honorary, Clinical Sciences) has led the team of surgeons at Leeds General Infirmary who have conducted the UK’s first hand transplant.For further information click here (January 2013)
Professor Tim Bishop (Cancer Studies & Pathology) has written to the International Journal of Cancer about research around the links between sunbed use and skin cancer. For further information click here (December 2012).
Dr James Thorne (Clinical Sciences) is set to investigate cancer cells’ resistance to therapies in two new studies. The one-year projects funded by the charity Yorkshire Cancer Research will concentrate on breast cancer, which is the most common cancer in the UK, and ovarian cancer, the fifth most common in women. For further information click here (December 2012).
Professor Andy Hanby (Cancer Studies & Pathology) has been involved in the development of a new interactive website which allows non-scientists to analyse cancer samples. For further information click here (November 2012).
Drs Penny Wright and Laura Ashley (Cancer Studies & Pathology) have received a Meritorious Award at the 6th Biennial Cancer Survivorship Research Conference recently held in Virginia, USA. Funded by Macmillan Cancer Support, they submitted their study on the electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) entitled 'Incorporating patient reported outcomes into UK cancer registries: preliminary results from feasibility testing of a novel electornic data collection and linkage system' (August 2012).
Dr Michael Backhouse (Rheumatic & Musculoskeletal Disease) has been awarded the Arthritis Research UK Silver Medal Research Prize for research he has carried out into the effect of surgery on patients with rheumatoid arthritis (August 2012).
Darren Tomlinson (Cancer Studies and Pathology) has been awarded the Chinese Academy of Sciences (CAS) Young International Scientist award. He has also been awarded the position of Guest Principal Investigator at CAS (July 2012).
Reuben Tooze (Cancer Studies and Pathology) is leading a team of researchers investigating how the cancer myeloma develops. The team will be studying how mutated genes within plasma cells, which cause cancers, work together to cause cancer cells to grow rapidly and destroy normal tissues. The work is funded by Yorkshire Cancer Research (July 2012).
Professor Alan Melcher (Cancer Studies & Pathology) is jointly leading research looking at how a viral therapy can hitch a ride on blood cells in order to sneak up on tumours. Click here for more details (June 2012).
Professor Paul Emery (Rheumatic & Musculoskeletal Disease) has been awarded the Carol Nachman Award - a worldwide premier award for rheumatology. Further information available here and here (May 2012).
An international collaboration to investigate the survival of skin cancer patients between scientists from LIMM, Europe and North America is set to begin. Click here for further information (February 2012).
The Breast Cancer Campaign Tissue Bank, which has a core centre in LIMM, is now open to the UK and Irish breast cancer research community. The Tissue Bank has been operating on a small scale over the past year but the doors are now open to applicants from across the UK and Ireland thanks to the hard work and commitment of the Leeds team and their collaborating partners elsewhere in the UK. Hot on the heels of the opening of the Breast Cancer Campaign Tissue Bank, the Leeds PI, Dr Valerie Speirs of the Division of Cancer and Pathology, visited the Komen Tissue Bank at the IU Simon Cancer Center in Indianapolis, USA. Her visit coincided with the Komen Tissue Bank’s unique "Super Cure" event where around 700 women volunteers attended the IU Simon Cancer Center over 2 days to donate samples of healthy breast tissue. It is hoped her visit will lead to greater collaborative effort between both Tissue Banks (January 2012).